📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
VASUNDHARA RASAYANS LTD.VRLPharmaceuticals
Open
118
High
124.2
Low
114.3
Close
117.4
Volume
1267
Exchange
bse
Time
12-Mar-2026

Outlook

Score:

4

Rating:

FAIR

Candlestick Pattern

CandlepatternofVasundharaRasayansis
High Wave
EstimatedStoplossofVasundharaRasayansis
124.2
VasundharaRasayanshasa
Bearishℹ
pattern.
Formationof
High Wave
candlepatternindicatesthetrenddirectionofVasundharaRasayansis
Unpredictableℹ
.

Trend

VasundharaRasayansisin
Sideways trendℹ
.
PriceofVasundharaRasayansis
Downℹ
by

15.18

%.
Target
Buy@

110.21

Sell@

187.69

Current@

117.4

Volume

ThetradevolumesofVasundharaRasayanshavebecome
Deficientℹ
ThevolumetrendforVasundharaRasayansis
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofVasundharaRasayansis

Down

by

28.19

%

Valuation

ThecurrentmarketpriceofVasundharaRasayansis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth43crandtotalassetsworth43cr,thebalancesheetofVasundharaRasayansis:
Balancedℹ
.
Cashflow
VasundharaRasayanshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 4cr

.Itis
Downℹ
by

500

%.
83.33% i.e. ₹ 5cr spent in operatingℹ
0% in investingℹ
16.67% i.e. ₹ 1cr earned in financingℹ
0% in otherℹ
VasundharaRasayanshas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 1cr

.Itis
Upℹ
by

133.33

%.
66.67% i.e. ₹ 6cr earned in operatingℹ
11.11% i.e. ₹ 1cr spent in investingℹ
22.22% i.e. ₹ 2cr spent in financingℹ
0% in otherℹ
Income
TheincomeofVasundharaRasayansis

₹ 9cr

and

Profit

is:

₹ 2cr

VasundharaRasayansProfitisupby:

200

%andIncomeisUpby:

12.5

%
TheincomeofVasundharaRasayansis

₹ 8cr

and

Loss

is:

₹ 0cr

VasundharaRasayansLossesincreasedby:

0

%andIncomeisUpby:

0

%
TheincomeofVasundharaRasayansis

₹ 8cr

and

Loss

is:

₹ 0cr

VasundharaRasayansLossesincreasedby:

100

%andIncomeisDownby:

11.11

%
By using this site you agree to the use of cookies to deliver a better site experience.